4-year outcomes of patients with aortic stenosis in the Evolut Low Risk trial

Authors

John K. Forrest, Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: john.k.forrest@yale.edu.
G Michael Deeb, University of Michigan Health Systems-University Hospital, Ann Arbor, Michigan, USA.Follow
Steven J. Yakubov, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.
Hemal Gada, University of Pittsburgh Medical Center, Harrisburg, Pennsylvania, USA.
Mubashir A. Mumtaz, University of Pittsburgh Medical Center, Harrisburg, Pennsylvania, USA.
Basel Ramlawi, Lankenau Heart Institute, Philadelphia, Pennsylvania, USA.
Tanvir Bajwa, Advocate Aurora HealthFollow
Paul S. Teirstein, Scripps Clinic, La Jolla, California, USA.
Didier Tchétché, Clinique Pasteur, Toulouse, France.
Jian Huang, Medtronic, Mounds View, Minnesota, USA.
Michael J. Reardon, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.

Recommended Citation

Forrest JK, Deeb GM, Yakubov SJ, et al. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. J Am Coll Cardiol. 2023;82(22):2163-2165. doi:10.1016/j.jacc.2023.09.813

Affiliations

Aurora St. Luke's Medical Center

Type

Letter

PubMed ID

37877907